WitrynaInternational Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma Treatment of multiple myeloma has … Witryna一、概述. 随着自体造血干细胞移植(autologous hematopoietic stem cell transplantation,ASCT)和新药在一线治疗中的应用,多发性骨髓瘤(multiple myeloma,MM)患者的总生存(overall survival,OS)期已明显延长,但MM仍是一种不可治愈的疾病 [1,2] ,患者终将面临复发。 复发按照发生次数分为首次复发(第一次 …
Statistical Analysis Plan Protocol Title: A Phase 1 Open-label Study ...
WitrynaThe IMWG guidelines for response assessment recommend MRD testing in the subset of patients achieving a complete hematological response. However, previous … WitrynaThe new IMWG criteria emphasize the role of imaging to risk-stratify SMM, with patients having two or more focal lesions >5 mm detected by MRI qualifying for active treatments. 43, 44 In particular, the IMWG recommends sensitive low-dose whole-body CT for the staging of monoclonal gammopathies. 45 This imaging technique was recently … include numbers in legend in excel
Statistical Analysis Plan for Study M13-367 (Portion2) A Phase 1/2 ...
WitrynaInternational Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma Summary Treatment of multiple myeloma has substantially changed over the past decade with the introduction of several classes of new effective drugs that have greatly improved the rates and depth of … Witryna8 gru 2024 · The International Myeloma Working Group (IMWG) has revised the criteria for MM. Progress in the treatment of newly diagnosed MM has been achieved … Witryna1 mar 2024 · The International Myeloma Working Group (IMWG) has published dozens of research studies and treatment guidelines on multiple myeloma and its related disorders. The following are a sample of the International Myeloma Working Group’s ranging publication topics: Genetic predisposition for chemotherapy-induced … include numpy python